270 related articles for article (PubMed ID: 23950183)
21. Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review.
Gladue H; Altorok N; Townsend W; McLaughlin V; Khanna D
Semin Arthritis Rheum; 2014 Feb; 43(4):536-41. PubMed ID: 24012044
[TBL] [Abstract][Full Text] [Related]
22. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
Thakkar V; Stevens W; Prior D; Rabusa C; Sahhar J; Walker JG; Roddy J; Lester S; Rischmueller M; Zochling J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):129-136. PubMed ID: 27214686
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS).
Kolstad KD; Li S; Steen V; Chung L;
Chest; 2018 Oct; 154(4):862-871. PubMed ID: 29777655
[TBL] [Abstract][Full Text] [Related]
24. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.
Humbert M; Yaici A; de Groote P; Montani D; Sitbon O; Launay D; Gressin V; Guillevin L; Clerson P; Simonneau G; Hachulla E
Arthritis Rheum; 2011 Nov; 63(11):3522-30. PubMed ID: 21769843
[TBL] [Abstract][Full Text] [Related]
25. Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests.
Schreiber BE; Valerio CJ; Keir GJ; Handler C; Wells AU; Denton CP; Coghlan JG
Arthritis Rheum; 2011 Nov; 63(11):3531-9. PubMed ID: 21769839
[TBL] [Abstract][Full Text] [Related]
26. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis.
Steen V; Chou M; Shanmugam V; Mathias M; Kuru T; Morrissey R
Chest; 2008 Jul; 134(1):146-51. PubMed ID: 18403670
[TBL] [Abstract][Full Text] [Related]
27. Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension.
Mathai SC; Sibley CT; Forfia PR; Mudd JO; Fisher MR; Tedford RJ; Lechtzin N; Boyce D; Hummers LK; Housten T; Zaiman AL; Girgis RE; Hassoun PM
J Rheumatol; 2011 Nov; 38(11):2410-8. PubMed ID: 21965638
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).
Wigley FM; Lima JA; Mayes M; McLain D; Chapin JL; Ward-Able C
Arthritis Rheum; 2005 Jul; 52(7):2125-32. PubMed ID: 15986394
[TBL] [Abstract][Full Text] [Related]
29. Screening for pulmonary arterial hypertension in patients with scleroderma--a New Zealand perspective.
Ghosh SK; Corkill MM; Hart HH; Ng KP
N Z Med J; 2014 Aug; 127(1400):30-8. PubMed ID: 25145365
[TBL] [Abstract][Full Text] [Related]
30. Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry.
Chung L; Domsic RT; Lingala B; Alkassab F; Bolster M; Csuka ME; Derk C; Fischer A; Frech T; Furst DE; Gomberg-Maitland M; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TA; Molitor JA; Preston IR; Schiopu E; Shapiro L; Silver R; Simms R; Varga J; Gordon JK; Steen VD
Arthritis Care Res (Hoboken); 2014 Mar; 66(3):489-95. PubMed ID: 23983198
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary arterial hypertension in Thai patients with systemic sclerosis.
Wangkaew S; Kasitanon N; Phrommintikul A; Sukitawut W; Wichainun R; Louthrenoo W
J Med Assoc Thai; 2008 Feb; 91(2):166-72. PubMed ID: 18389980
[TBL] [Abstract][Full Text] [Related]
32. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.
Tedford RJ; Mudd JO; Girgis RE; Mathai SC; Zaiman AL; Housten-Harris T; Boyce D; Kelemen BW; Bacher AC; Shah AA; Hummers LK; Wigley FM; Russell SD; Saggar R; Saggar R; Maughan WL; Hassoun PM; Kass DA
Circ Heart Fail; 2013 Sep; 6(5):953-63. PubMed ID: 23797369
[TBL] [Abstract][Full Text] [Related]
33. Performance of screening algorithms in systemic sclerosis-related pulmonary arterial hypertension: a systematic review.
Thakkar V; Stevens WM; Moore OA; Nikpour M
Intern Med J; 2013 Jul; 43(7):751-60. PubMed ID: 23611651
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.
Vilela VS; Dias MM; Salgado ÂA; da Silva BRA; Lopes AJ; Bessa EJC; Bruno LP; da Costa CH; Levy RA; Rufino R
BMC Pulm Med; 2021 Jul; 21(1):251. PubMed ID: 34325685
[TBL] [Abstract][Full Text] [Related]
35. Bosentan in pulmonary arterial hypertension secondary to scleroderma.
Joglekar A; Tsai FS; McCloskey DA; Wilson JE; Seibold JR; Riley DJ
J Rheumatol; 2006 Jan; 33(1):61-8. PubMed ID: 16395751
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis.
Ciurzyński M; Bienias P; Irzyk K; Rymarczyk Z; Kostrubiec M; Szewczyk A; Glińska-Wielochowska M; Zyłkowska J; Kurzyna M; Pruszczyk P
Kardiol Pol; 2011; 69(1):9-15. PubMed ID: 21267956
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.
Zhang N; Li M; Qian J; Wang Q; Zhao J; Yang Z; Tian Z; Zhang X; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wei W; Zeng X
Int J Rheum Dis; 2019 May; 22(5):921-928. PubMed ID: 30746850
[TBL] [Abstract][Full Text] [Related]
38. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.
Hachulla E; Gressin V; Guillevin L; Carpentier P; Diot E; Sibilia J; Kahan A; Cabane J; Francès C; Launay D; Mouthon L; Allanore Y; Tiev KP; Clerson P; de Groote P; Humbert M
Arthritis Rheum; 2005 Dec; 52(12):3792-800. PubMed ID: 16320330
[TBL] [Abstract][Full Text] [Related]
39. Impact of the COVID-19 Pandemic on Health Care Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients With Systemic Sclerosis.
Callisto A; Hansen D; Walker J; Ngian GS; Apostolopoulos D; Liew D; Chand V; Hill CL; Griggs K; Calderone A; Nikpour M; Sahhar J; Stevens W; Proudman S
Arthritis Care Res (Hoboken); 2024 Jan; 76(1):81-87. PubMed ID: 37728139
[TBL] [Abstract][Full Text] [Related]
40. Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients.
Shah AA; Chung SE; Wigley FM; Wise RA; Hummers LK
Ann Rheum Dis; 2013 Jul; 72(7):1136-40. PubMed ID: 22887850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
